Wolverine Trading
XBI icon

Wolverine Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Wolverine Trading’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$31.5M Sell
317,100
-77,500
-20% -$6.98M 0.02% 454
2025
Q2 		$32.8M Buy
394,600
+85,800
+28% +$6.84M 0.03% 330
2025
Q1 		$26.1M Sell
308,800
-142,300
-32% -$12.7M 0.03% 334
2024
Q4 		$40.5M Sell
451,100
-24,400
-5% -$2.36M 0.04% 281
2024
Q3 		$46.8M Buy
475,500
+97,300
+26% +$9.56M 0.05% 221
2024
Q2 		$35.1M Sell
378,200
-153,200
-29% -$13.7M 0.04% 266
2024
Q1 		$50.4M Buy
531,400
+23,300
+5% +$2.16M 0.05% 189
2023
Q4 		$45.4M Buy
508,100
+121,800
+32% +$9.05M 0.05% 238
2023
Q3 		$28.2M Buy
+386,300
New +$30.9M 0.03% 279
2023
Q2 		– Sell
-481,200
Closed -$35.9M – 5069
2023
Q1 		$35.9M Sell
481,200
-146,000
-23% -$12.1M 0.06% 213
2022
Q4 		$52.1M Sell
627,200
-14,400
-2% -$1.17M 0.08% 187
2022
Q3 		$50.6M Sell
641,600
-17,000
-3% -$1.43M 0.08% 138
2022
Q2 		$49.3M Buy
658,600
+92,500
+16% +$6.94M 0.08% 125
2022
Q1 		$51.3M Sell
566,100
-54,300
-9% -$5.01M 0.07% 172
2021
Q4 		$70.3M Sell
620,400
-117,100
-16% -$14.1M 0.08% 155
2021
Q3 		$92.7M Buy
737,500
+308,900
+72% +$39.8M 0.1% 116
2021
Q2 		$58.2M Sell
428,600
-3,600
-0.8% -$473K 0.09% 160
2021
Q1 		$56.2M Sell
432,200
-160,700
-27% -$24.1M 0.08% 148
2020
Q4 		$85.4M Buy
+592,900
New +$75.9M 0.13% 89
2020
Q3 		– Sell
-644,400
Closed -$71.1M – 5271
2020
Q2 		$71.1M Buy
644,400
+179,000
+38% +$17.6M 0.19% 63
2020
Q1 		$36.3M Sell
465,400
-16,200
-3% -$1.43M 0.11% 124
2019
Q4 		$45.6M Buy
+481,600
New +$41.7M 0.11% 124
2019
Q3 		– Sell
-493,300
Closed -$43.3M – 5130
2019
Q2 		$43.3M Buy
493,300
+23,000
+5% +$1.96M 0.12% 111
2019
Q1 		$42.6M Buy
470,300
+63,400
+16% +$5.39M 0.12% 109
2018
Q4 		$28.5M Buy
406,900
+75,400
+23% +$6.08M 0.08% 168
2018
Q3 		$31.8M Buy
331,500
+93,300
+39% +$9.05M 0.07% 182
2018
Q2 		$20.9M Hold
238,200
– – 0.05% 239
2018
Q1 		$20.9M Sell
238,200
-60,000
-20% -$5.48M 0.05% 239
2017
Q4 		$25.3M Buy
298,200
+92,100
+45% +$7.72M 0.09% 182
2017
Q3 		$17.8M Sell
206,100
-114,000
-36% -$9.14M 0.07% 245
2017
Q2 		$25M Buy
320,100
+30,600
+11% +$2.17M 0.12% 159
2017
Q1 		$20M Buy
289,500
+26,600
+10% +$1.79M 0.11% 182
2016
Q4 		$15.6M Buy
262,900
+18,100
+7% +$1.12M 0.08% 271
2016
Q3 		$16M Sell
244,800
-39,300
-14% -$2.43M 0.07% 293
2016
Q2 		$15.4M Buy
+284,100
New +$15.6M 0.09% 226

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wolverine Trading's XBI Position: Q3 2025 in Review

Wolverine Trading reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 16% in Q3 2025, selling an estimated $1.07M and leaving 61,981 shares worth $6.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1232.

Wolverine Trading first reported a position in XBI in Q2 2016 and has held it in 35 quarters since. The position peaked at $18.1M in Q4 2021. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • Wolverine Trading held 61,981 shares of State Street SPDR S&P Biotech ETF worth $6.16M as of Q3 2025.
  • Wolverine Trading sold 11,862 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $1.07M.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #1232 holding.
  • Wolverine Trading first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and has held it in 35 quarters since.
  • Wolverine Trading's State Street SPDR S&P Biotech ETF position peaked at $18.1M in Q4 2021.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.